Reply  by De Maeseneer, Marianne G.
LETTERS TO THE EDITOR
Regarding “Early and late complications of silicone
patch saphenoplasty at the saphenofemoral junction”
The authors are to be commended for their detailed study on
complications that can occur after silicone patch saphenoplasty in
order to decrease neovascularity after groin dissection for saphe-
nous ligation.1 There is a varying incidence of this phenomenon
after standard surgical intervention.2 Even with their efforts of
patch interposition, neovascularity was evident at one year. Given
more follow-up, the rate will grow since this phenomenon may
increase with time.
In my experience, neovascularity is an important cause of
recurrent varices after surgery. I have two points regarding mini-
mizing the incidence of neovascularity. First utilize the technique
of endovenous ablation (laser). In our series of over 3000 patients
covering a span of 5 years, we have seen only one case of neovas-
cularity at the groin level with follow-up ultrasounds. I believe this
occurs for two reasons. (1) There is no groin dissection with
resultant inflammatory response. (2) Flow continues at the saphe-
nofemoral junction, negating the natural response to form collat-
eral pathways.
Next, for neovascularity that occurs after a primary procedure,
utilize the technique of ultrasound guided injection of 1.5% Sotra-
decol foam.3 This technique is safe and effective in obliterating
these small vessels. The typical vessels of neovascularity are valve-
less and communicate freely. Only 2 to 3 cc of foam is needed to
effectively fill the vessels. Injection can safely be done since most of
these collateral vessels are easily accessed 2 to 3 cm above the
femoral vein. After injection, the femoral vein is partially com-
pressed to keep the foam in place for 3 minutes. The patient
dorsiflexes the foot at the same time to clear any foam from the
femoral vein. In over 120 patients treated in the last 3 years for
neovascularity at the saphenofemoral junction, there have been no
incidences of deep venous thrombosis (DVT). Repeat groin dis-
sections should be avoided since this only eventually aggravates the
problem.
The techniques briefly described in this response are effective,
minimally invasive, and associated with no incidence of DVT and
few significant complications. Surgeons not doing these proce-
dures should learn them.
Ronald G. Bush, MD, FACS
Midwest Vein Treatment Clinic
Dayton, Ohio
REFERENCES
1. Maeseneer MG, Vandenbroeck CP, Lauwers PR, Hendricks JM, et al.
Early and late complications of silicone patch saphenoplasty at the
saphenofemoral junction. J Vasc Surgery 2006;44:1285-90.
2. Fischer R, Chandler JG, De Maeseneer, Frings N, Lefebvre-Velardebo
M, Earnshaw JJ, et al. The unresolved problem of recurrent saphe-
nofemoral reflux. J Am Coll Surg 2002;195:80-94.
3. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by
foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8.
doi:10.1016/j.jvs.2006.12.078
Reply
I thank Dr Bush for his interest in our study. It is indeed
correct that after properly performed surgery at the saphenofemo-
ral junction (SFJ), neovascularization remains a problem. Patch
saphenoplasty can never completely eliminate this postoperative
phenomenon, but it can at least mitigate the effects of neovascu-
larization, which may result in a better clinical outcome at long-
term follow-up.1
I fully agree that alternative techniques with the aim of
obliterating the great saphenous vein (GSV) have shown prom-
ising results, with a very low incidence of neovascularization.
The 5-year results of endovenous procedures with radiofre-
quency obliteration have already been published.2 I look for-
ward to the publication of the 5-year results of a “properly
done” study on endovenous laser treatment, as well as more
randomized controlled trials comparing different techniques for
treating primary varicose veins.
However, regarding the application of these newer tech-
niques, some points should be kept in mind. First, there is the need
for a meticulous preoperative and intraoperative duplex scanning
requiring sufficient knowledge and experience in this field.
Second, endovenous procedures are not always feasible in
all patients with primary varicose veins in the GSV territory
because of anatomical variations, tortuosity, or even aneurysmal
dilations of the veins. In such patients, well-performed surgery
might still offer a valuable alternative and construction of a
prosthetic or anatomical barrier at the SFJ ligation site might be
useful.
Finally, technical equipment for endovenous procedures is not
yet available in all surgical centers because these devices and the
catheters used are quite expensive.
Foam sclerotherapy may be an adequate tool, in particular to
treat patients with small saphenous vein (SSV) insufficiency and
also those with recurrent varicose veins due to neovascular veins in
the groin.
Of course, there is no indication for surgical re-exploration of
the groin if only small vessels are visualized on duplex scan.
However in selected cases, for instance in young patients present-
ing with very extensive symptomatic recurrent varicose veins and
large refluxing veins at the SFJ on duplex ultrasound imaging
(often after too superficial previous surgery), repeat surgery, in
experienced hands, may still have a place. Five years after repeat
surgery with patch saphenoplasty, 85% of limbs had a venous
clinical severity score 3, and only 26 % had recurrent thigh
varicosities.1
Until further evidence, surgical trainees should learn all of the
above-mentioned surgical and endovenous techniques to be able
to offer the best solution to each patient presenting with varicose
veins.
Marianne G. De Maeseneer, MD, PhD
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